Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Operations

v3.3.1.900
Condensed Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
REVENUES $ 0 $ 0
OPERATING EXPENSES    
Research and development expenses 3,554,000 2,534,000
General and administrative expenses 4,085,000 2,258,000
Stock compensation expense 1,611,000 1,087,000
Depreciation and amortization 491,000 220,000
TOTAL OPERATING EXPENSES 9,741,000 6,099,000
OPERATING LOSS (9,741,000) (6,099,000)
OTHER INCOME (EXPENSE)    
Interest and investment income 27,000 29,000
Interest expense 0 (2,808,000)
Fair value adjustments to warrant and derivative liabilities 0 (2,016,000)
Other income 0 1,164,000
TOTAL OTHER INCOME (EXPENSE) 27,000 (3,631,000)
LOSS BEFORE INCOME TAXES (9,714,000) (9,730,000)
Provision for income taxes (1,000) (1,000)
NET LOSS $ (9,715,000) $ (9,731,000)
NET LOSS PER SHARE - BASIC AND DILUTED $ (1.36) $ (2.16)
Weighted average shares outstanding — basic and diluted 7,160,567 4,510,242